Molecular Neuroimaging in the Study of Cognitive Impairment: Contribution of the Cerebral Blood Flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT Scan
- 31 October 2011
- journal article
- Published by Elsevier in Revista Española de Medicina Nuclear (English Edition)
- Vol. 30 (5) , 301-306
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- EFNS guidelines for the diagnosis and management of Alzheimer’s diseaseEuropean Journal of Neurology, 2010
- Neuroimagen: Fundamentos técnicos y prácticosRevista Española de Medicina Nuclear, 2010
- Temporal Hypoperfusion Assessed by Cerebral Blood Flow SPECT and Long-Term Clinical Outcome in Patients With Eating DisordersClinical Nuclear Medicine, 2009
- Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine, 2008
- Mild cognitive impairment (MCI): a historical perspectiveInternational Psychogeriatrics, 2007
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]Neurology, 2001
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- Semi-quantitative assessment of cerebral blood flow with 99m Tc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991